Your AAV partner
from bench
to clinic

ABOUT US

Who we are

Innovavector is a young-accomplished CDMO well established in the world of gene therapy, bringing experience and innovation in the production of adeno-associated viral vectors from bench to manufacturing.

• Young

  Founded in 2020 as a spin-off of the Telethon Institute of Genetics and Medicine (TIGEM), Innovavector brings a dynamic team that leads a new and innovative vision in the development of gene therapies.

• Experienced

  The company leverages the 20+ years of experience of TIGEM and Alberto Auricchio’s Vector Core team in developing, optimizing and manufacturing AAVs for gene therapy applications.

Discover more